Exevir Bio

Provider of antibody-based therapies to monitor viral infections

placeGhent, Flanders, Belgium calendar_todayFounded 2020 groups11 employees language exevir.com

Registered entities

Investor mix

11 investors on record; lead investors include Fund+.

Investor typeCountShare
Venture capital545%
Private equity436%
Other / undisclosed218%
Coming soon